Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
(NYSE : NUVO) Stock
MWN-AI** Summary
MWN-AI** Analysis
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Description
Nuvo is leading a transformation in pregnancy care by providing clinicians and expectant mothers with access to medically-necessary remote pregnancy monitoring anytime, anywhere. Nuvo¿s INVU¿ platform is an FDA-cleared remote pregnancy monitoring and management system. It enables the delivery of remote non-stress tests (NSTs) and maternal and fetal heart rate monitoring, while pioneering new data-driven personalized pathways that can improve future health outcomes. INVU is being used by leading health providers and research institutions across the US and Israel. Nuvo will continue to expand the footprint of sales in the US and Israel and plans to introduce the product in Europe in 2024 following the hoped for granting of the CE mark in 2024 to provide remote access and insights not previously deemed possible.
Quote
| Last: | $0.65 |
|---|---|
| Change Percent: | 2.14% |
| Open: | $0.71 |
| Close: | $0.65 |
| High: | $0.71 |
| Low: | $0.65 |
| Volume: | 18,665 |
| Last Trade Date Time: | 08/02/2024 03:00:00 am |
Stock Data
| Market Cap: | $0 |
|---|---|
| Float: | N/A |
| Insiders Ownership: | N/A |
| Institutions: | |
| Short Percent: | N/A |
| Industry: | |
| Sector: | |
| Country: | |
| City: |
Recent News Releases
Subscribe to Our Newsletter
**MWN-AI FAQ is based on asking OpenAI questions about (NYSE: NUVO).
